Drug Database
Back to search

Finland· FI-REL-REL51914

Relafalk

A rifamycin product containing rifamycin sodium, registered in Finland by Adalvo Competence Center S.R.L.. The same ATC class is registered in 2 of our 19 countries.

ATC A07AA13

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedRelafalkATCA07AA13REGISTER NO.FI-REL-REL51914PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rifamycin sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rifamycin is registered in 2 of 19 countries.

Countries holding a registration under ATC A07AA13 (rifamycin), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose
Search rifamycin products by name

Rifamycin · ATC A07AA13

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Rifamycin sodium
Manufacturer
Adalvo Competence Center S.R.L.
Country
Finland (FI)
ATC code
A07AA13
ATC class
Rifamycin
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for rifamycin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rifamycin against other medicinesHow interaction checks work

Rifamycin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifamycin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifamycin products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Rifocine I.V.
  • Bulgaria · Relafalk
  • Germany · Gutivia
  • France · Otofa, Rifamycine Chibret
  • Greece · Relafalk
  • Hungary · Relafalk
  • Italy · Dotecine, Rifocin
  • Luxembourg · Otofa, Rifocine I.V.
  • Norway · Relafalk
  • Poland · Relafalk
  • Portugal · Imfalda, Rifocina
  • Sweden · Relafalk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a3a72b32-d089-4336-86ed-6c013a0879d9
GET /v1/drugs/a3a72b32-d089-4336-86ed-6c013a0879d9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "0.8",
  "form": "säädellysti vapauttava tabletti",
  "route": "Suun kautta",
  "ddd_unit": "g",
  "strength": "200 mg",
  "atc_label": "rifamysiini",
  "ma_number": "35622",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL51914",
  "authorised_at": "2019-03-04"
}
API referenceMCP serverPlans

See everything about rifamycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console